Efficacy and safety of immune checkpoint inhibitors in lung large-cell neuroendocrine carcinoma.

J Thorac Dis · 2023 · PMC10482626 · PMID 37691658

Europe PMC DOI

hedged sentence

0.2330

closest p · 4.7× alpha

0.2330

boldest claim

The sentences

did not reach statistical significanceP=0.233not close (p > 0.1)

5.60 months, P=0.032), while OS showed a longer duration but did not reach statistical significance (21.27 vs. 14.73 months, P=0.233), possibly due to the small sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.